Cargando…

α-Klotho, Plasma Asymmetric Dimethylarginine, and Kidney Disease Progression

RATIONALE & OBJECTIVE: We aimed to explore the associated factors of endothelial injury in chronic kidney disease (CKD) and the relationship between endothelial dysfunction and CKD prognosis. STUDY DESIGN: A prospective observational cohort study. SETTING & PARTICIPANTS: 77 adults with CKD s...

Descripción completa

Detalles Bibliográficos
Autores principales: Qian, Jing, Zhong, Jianyong, Liu, Shaojun, Yan, Minhua, Cheng, Ping, Hao, Chuanming, Gu, Yong, Lai, Lingyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664695/
https://www.ncbi.nlm.nih.gov/pubmed/34939007
http://dx.doi.org/10.1016/j.xkme.2021.05.008
_version_ 1784613897592897536
author Qian, Jing
Zhong, Jianyong
Liu, Shaojun
Yan, Minhua
Cheng, Ping
Hao, Chuanming
Gu, Yong
Lai, Lingyun
author_facet Qian, Jing
Zhong, Jianyong
Liu, Shaojun
Yan, Minhua
Cheng, Ping
Hao, Chuanming
Gu, Yong
Lai, Lingyun
author_sort Qian, Jing
collection PubMed
description RATIONALE & OBJECTIVE: We aimed to explore the associated factors of endothelial injury in chronic kidney disease (CKD) and the relationship between endothelial dysfunction and CKD prognosis. STUDY DESIGN: A prospective observational cohort study. SETTING & PARTICIPANTS: 77 adults with CKD stages 1-5 were enrolled January 2010 to December 2010 and followed up until December 2015. EXPOSURE: Serum asymmetric dimethylarginine (ADMA) level at baseline, α-klotho, sodium-phosphorus synergistic transporter, and dimethylarginine-dimethylamine hydrolase expression in kidney biopsy samples. OUTCOME: Initiation of kidney replacement therapy (KRT). ANALYTICAL APPROACH: Kaplan-Meier analysis was used for evaluation of the incidence rate of KRT. All tests were 2 tailed, and statistical significance was defined as P < 0.05. RESULTS: Mean serum ADMA level of 77 patients was 64.3 ± 34.6 ng/mL. ADMA level increased with CKD stages (P = 0.06) and declining kidney function (r = −0.267; P = 0.02). The expression of α-klotho in kidney biopsy specimens also decreased. Median follow-up time was 56 (interquartile range, 50.5-62) months. Kaplan-Meier analyses showed that during a total follow-up of 6 years, the incidence of KRT initiation in the high-ADMA group was significantly higher than that in the low group (35.9% vs 13.2%; P = 0.03). ADMA level was negatively correlated with α-klotho (r = −0.233; P = 0.04) and positively correlated with phosphorus level (r = 0.243; P = 0.04). The expression of sodium-phosphorus synergistic transporter in kidney tubules, which promoted phosphorus reabsorption, and the expression of dimethylarginine-dimethylamine hydrolase isoform 1, which regulated ADMA, were decreased. Correlation analysis also showed that ADMA level decreased while age increased at baseline (r = −0.292; P = 0.01). LIMITATIONS: Small sample size with limited longer-term follow-up. CONCLUSIONS: Serum ADMA levels increased as kidney function declined, and high serum ADMA level was associated with incident kidney failure. Low tissue α-klotho and high levels of plasma phosphorus or tissue expression of type II sodium/phosphate cotransporter in the kidney are associated with higher circulating ADMA levels, suggesting that they may be involved in the pathogenesis of endothelial dysfunction in patients with CKD.
format Online
Article
Text
id pubmed-8664695
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-86646952021-12-21 α-Klotho, Plasma Asymmetric Dimethylarginine, and Kidney Disease Progression Qian, Jing Zhong, Jianyong Liu, Shaojun Yan, Minhua Cheng, Ping Hao, Chuanming Gu, Yong Lai, Lingyun Kidney Med Original Research RATIONALE & OBJECTIVE: We aimed to explore the associated factors of endothelial injury in chronic kidney disease (CKD) and the relationship between endothelial dysfunction and CKD prognosis. STUDY DESIGN: A prospective observational cohort study. SETTING & PARTICIPANTS: 77 adults with CKD stages 1-5 were enrolled January 2010 to December 2010 and followed up until December 2015. EXPOSURE: Serum asymmetric dimethylarginine (ADMA) level at baseline, α-klotho, sodium-phosphorus synergistic transporter, and dimethylarginine-dimethylamine hydrolase expression in kidney biopsy samples. OUTCOME: Initiation of kidney replacement therapy (KRT). ANALYTICAL APPROACH: Kaplan-Meier analysis was used for evaluation of the incidence rate of KRT. All tests were 2 tailed, and statistical significance was defined as P < 0.05. RESULTS: Mean serum ADMA level of 77 patients was 64.3 ± 34.6 ng/mL. ADMA level increased with CKD stages (P = 0.06) and declining kidney function (r = −0.267; P = 0.02). The expression of α-klotho in kidney biopsy specimens also decreased. Median follow-up time was 56 (interquartile range, 50.5-62) months. Kaplan-Meier analyses showed that during a total follow-up of 6 years, the incidence of KRT initiation in the high-ADMA group was significantly higher than that in the low group (35.9% vs 13.2%; P = 0.03). ADMA level was negatively correlated with α-klotho (r = −0.233; P = 0.04) and positively correlated with phosphorus level (r = 0.243; P = 0.04). The expression of sodium-phosphorus synergistic transporter in kidney tubules, which promoted phosphorus reabsorption, and the expression of dimethylarginine-dimethylamine hydrolase isoform 1, which regulated ADMA, were decreased. Correlation analysis also showed that ADMA level decreased while age increased at baseline (r = −0.292; P = 0.01). LIMITATIONS: Small sample size with limited longer-term follow-up. CONCLUSIONS: Serum ADMA levels increased as kidney function declined, and high serum ADMA level was associated with incident kidney failure. Low tissue α-klotho and high levels of plasma phosphorus or tissue expression of type II sodium/phosphate cotransporter in the kidney are associated with higher circulating ADMA levels, suggesting that they may be involved in the pathogenesis of endothelial dysfunction in patients with CKD. Elsevier 2021-07-29 /pmc/articles/PMC8664695/ /pubmed/34939007 http://dx.doi.org/10.1016/j.xkme.2021.05.008 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Research
Qian, Jing
Zhong, Jianyong
Liu, Shaojun
Yan, Minhua
Cheng, Ping
Hao, Chuanming
Gu, Yong
Lai, Lingyun
α-Klotho, Plasma Asymmetric Dimethylarginine, and Kidney Disease Progression
title α-Klotho, Plasma Asymmetric Dimethylarginine, and Kidney Disease Progression
title_full α-Klotho, Plasma Asymmetric Dimethylarginine, and Kidney Disease Progression
title_fullStr α-Klotho, Plasma Asymmetric Dimethylarginine, and Kidney Disease Progression
title_full_unstemmed α-Klotho, Plasma Asymmetric Dimethylarginine, and Kidney Disease Progression
title_short α-Klotho, Plasma Asymmetric Dimethylarginine, and Kidney Disease Progression
title_sort α-klotho, plasma asymmetric dimethylarginine, and kidney disease progression
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664695/
https://www.ncbi.nlm.nih.gov/pubmed/34939007
http://dx.doi.org/10.1016/j.xkme.2021.05.008
work_keys_str_mv AT qianjing aklothoplasmaasymmetricdimethylarginineandkidneydiseaseprogression
AT zhongjianyong aklothoplasmaasymmetricdimethylarginineandkidneydiseaseprogression
AT liushaojun aklothoplasmaasymmetricdimethylarginineandkidneydiseaseprogression
AT yanminhua aklothoplasmaasymmetricdimethylarginineandkidneydiseaseprogression
AT chengping aklothoplasmaasymmetricdimethylarginineandkidneydiseaseprogression
AT haochuanming aklothoplasmaasymmetricdimethylarginineandkidneydiseaseprogression
AT guyong aklothoplasmaasymmetricdimethylarginineandkidneydiseaseprogression
AT lailingyun aklothoplasmaasymmetricdimethylarginineandkidneydiseaseprogression